NMT, AGA Medical Pursue PFO Indication Following Septal Defect Approvals

Nitinol Medical Technologies' CardioSeal approval for ventricular septal defects Dec. 5 paves the way for pursuit of expanded approval to treat the much larger population with patent foramen ovale, the firm says